As of 2024-12-13, the Relative Valuation of Immunitybio Inc (IBRX) is (10.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.04 USD, the upside of Immunitybio Inc based on Relative Valuation is -449.4%.
The range of the Relative Valuation is (11.04) - (11.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 24.4x | 17.5x |
| Forward P/E multiples | 19.3x - 19.6x | 19.6x |
| Fair Price | (11.04) - (11.22) | (10.62) |
| Upside | -463.2% - -469.2% | -449.4% |
| Date | P/E |
| 2024-12-12 | -5.31 |
| 2024-12-11 | -5.50 |
| 2024-12-10 | -8.10 |
| 2024-12-09 | -8.38 |
| 2024-12-06 | -8.66 |
| 2024-12-05 | -7.98 |
| 2024-12-04 | -8.28 |
| 2024-12-03 | -7.96 |
| 2024-12-02 | -8.68 |
| 2024-11-29 | -8.80 |
| 2024-11-27 | -8.91 |
| 2024-11-26 | -8.94 |
| 2024-11-25 | -8.80 |
| 2024-11-22 | -8.91 |
| 2024-11-21 | -8.79 |
| 2024-11-20 | -8.51 |
| 2024-11-19 | -9.34 |
| 2024-11-18 | -8.75 |
| 2024-11-15 | -7.84 |
| 2024-11-14 | -8.50 |
| 2024-11-13 | -8.43 |
| 2024-11-12 | -8.64 |
| 2024-11-11 | -9.52 |
| 2024-11-08 | -9.73 |
| 2024-11-07 | -9.26 |
| 2024-11-06 | -9.46 |
| 2024-11-05 | -9.50 |
| 2024-11-04 | -9.08 |
| 2024-11-01 | -9.22 |
| 2024-10-31 | -9.10 |
| 2024-10-30 | -9.85 |
| 2024-10-29 | -9.80 |
| 2024-10-28 | -10.77 |
| 2024-10-25 | -9.29 |
| 2024-10-24 | -7.35 |
| 2024-10-23 | -6.04 |
| 2024-10-22 | -6.09 |
| 2024-10-21 | -6.20 |
| 2024-10-18 | -6.20 |
| 2024-10-17 | -6.01 |
| 2024-10-16 | -6.48 |
| 2024-10-15 | -6.46 |
| 2024-10-14 | -6.50 |
| 2024-10-11 | -6.37 |
| 2024-10-10 | -5.64 |
| 2024-10-09 | -5.80 |
| 2024-10-08 | -6.15 |
| 2024-10-07 | -6.09 |
| 2024-10-04 | -5.99 |
| 2024-10-03 | -5.94 |